A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-α-like effector A (CIDEA) in adipocyte lipolysis and obesity

被引:155
作者
Nordström, EA
Rydén, M
Backlund, EC
Dahlman, I
Kaaman, M
Blomqvist, L
Cannon, B
Nedergaard, J
Arner, P
机构
[1] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, SE-14186 Stockholm, Sweden
[2] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden
[3] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Surg, SE-14186 Stockholm, Sweden
关键词
D O I
10.2337/diabetes.54.6.1726
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated circulating fatty acid concentration is a hallmark of insulin resistance and is at least in part attributed to the action of adipose tissue-derived tumor necrosis factor-alpha (TNF-alpha) on lipolysis. Cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDER) belongs to a family of proapoptotic proteins that has five known members in humans and mice. The action of CIDER is unknown, but CIDER-null mice are resistant to obesity and diabetes. We investigated CIDER in adipose tissue of obese and lean humans and mice. The mRNA was expressed in white human fat cells and in brown mouse adipocytes. The adipose mRNA expression of CIDER in mice was not influenced by obesity. However, CIDER expression was decreased twofold in obese humans and normalized after weight reduction. Low adipose CIDER expression was associated with several features of the metabolic syndrome. Human adipocyte depletion of CIDER by RNA interference stimulated lipolysis and increased TNF-alpha secretion by a posttranscriptional effect. Conversely, TNF-alpha treatment decreased adipocyte CIDER expression via the mitogen-activated protein kinase c-Jun NH2-terminal kinase. We propose an important and human-specific role for CIDER in lipolysis regulation and metabolic complications of obesity, which is at least in part mediated by cross-talk between CIDER and TNF-alpha.
引用
收藏
页码:1726 / 1734
页数:9
相关论文
共 43 条
[1]  
ARNER P, 1976, ACTA MED SCAND, V200, P179
[2]   Depot-specific differences in perilipin mRNA but not protein expression in obesity [J].
Arvidsson, E ;
Blomqvist, L ;
Rydén, M .
JOURNAL OF INTERNAL MEDICINE, 2004, 255 (05) :595-601
[3]   Fatty acid metabolism in obesity and type 2 diabetes mellitus [J].
Blaak, EE .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2003, 62 (03) :753-760
[4]   Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans [J].
Bruun, JM ;
Lihn, AS ;
Verdich, C ;
Pedersen, SB ;
Toubro, S ;
Astrup, A ;
Richelsen, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (03) :E527-E533
[5]   Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk [J].
Carr, MC ;
Brunzell, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2601-2607
[6]   Obesity: epidemiology and possible prevention [J].
Caterson, ID ;
Gill, TP .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 16 (04) :595-610
[7]  
DANESCH U, 1992, J BIOL CHEM, V267, P7185
[8]   Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas [J].
Emoto, M ;
Nishizawa, Y ;
Maekawa, K ;
Hiura, Y ;
Kanda, H ;
Kawagishi, T ;
Shoji, T ;
Okuno, Y ;
Morii, H .
DIABETES CARE, 1999, 22 (05) :818-822
[9]   Tumor necrosis factor α stimulates lipolysis in adipocytes by decreasing Gi protein concentrations [J].
Gasic, S ;
Tian, B ;
Green, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6770-6775
[10]   TUMOR-NECROSIS-FACTOR INCREASES THE RATE OF LIPOLYSIS IN PRIMARY CULTURES OF ADIPOCYTES WITHOUT ALTERING LEVELS OF HORMONE-SENSITIVE LIPASE [J].
GREEN, A ;
DOBIAS, SB ;
WALTERS, DJA ;
BRASIER, AR .
ENDOCRINOLOGY, 1994, 134 (06) :2581-2588